Product nameAnti-ACSS2 antibody
See all ACSS2 primary antibodies
DescriptionRabbit polyclonal to ACSS2
Tested applicationsSuitable for: WBmore details
Unsuitable for: IP
Species reactivityReacts with: Human
Predicted to work with: Mouse
Synthetic peptide within Human ACSS2 aa 450-500. The exact sequence is proprietary.
Database link: Q9NR19
- WB: HepG2, HeLa, HEK-293T and Jurkat whole cell lysates.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: Tris citrate/phosphate
pH 7 to 8
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab264391 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/2000 - 1/10000. Predicted molecular weight: 79 kDa.|
FunctionActivates acetate so that it can be used for lipid synthesis or for energy generation.
Sequence similaritiesBelongs to the ATP-dependent AMP-binding enzyme family.
- Information by UniProt
- ACAS2 antibody
- AceCS antibody
- Acetate CoA ligase antibody
All lanes : Anti-ACSS2 antibody (ab264391) at 0.1 µg/ml
Lane 1 : HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate
Lane 2 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Lane 3 : HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate
Lane 4 : Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate
Lysates/proteins at 50 µg per lane.
Developed using the ECL technique.
Predicted band size: 79 kDa
Exposure time: 3 minutes
Lysates prepared using NETN lysis buffer.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab264391 has not yet been referenced specifically in any publications.